Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (1201-1210 of 22,015) with videos related to

Pageof 2,202
Sort By:
Oncogene|June 14, 2011
Identification and functional analysis of 9p24 amplified genes in human breast cancerJ Wu, S Liu, G Liu, et al.
Oncogene|December 16, 2014
Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesisA A Bhat, J L Pope, J J Smith, et al.
Oncogene|December 16, 2014
MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genesI Keklikoglou, K Hosaka, C Bender, et al.
Oncogene|September 29, 2015
USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2Z Li, Q Hao, J Luo, et al.
Oncogene|September 22, 2015
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cellsF F Blanco, M Jimbo, J Wulfkuhle, et al.
Oncogene|September 22, 2015
ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expressionE Sánchez-Tilló, O de Barrios, E Valls, et al.
Oncogene|September 22, 2015
Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cellsF Nitzki, N Cuvelier, J Dräger, et al.
Oncogene|September 22, 2015
Targeting PYK2 mediates microenvironment-specific cell death in multiple myelomaM B Meads, B Fang, L Mathews, et al.
Oncogene|August 11, 2015
Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasionS-Y Yen, S-R Chen, J Hsieh, et al.
Oncogene|August 11, 2015
Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancerD Merino, S W Lok, J E Visvader, et al.
Pageof 2,202

Showing results (1201-1210 of 22,015) with videos related to

Sort By:
Pageof 2,202
Oncogene|June 14, 2011
Identification and functional analysis of 9p24 amplified genes in human breast cancerJ Wu, S Liu, G Liu, et al.
Oncogene|December 16, 2014
Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesisA A Bhat, J L Pope, J J Smith, et al.
Oncogene|December 16, 2014
MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genesI Keklikoglou, K Hosaka, C Bender, et al.
Oncogene|September 29, 2015
USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2Z Li, Q Hao, J Luo, et al.
Oncogene|September 22, 2015
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cellsF F Blanco, M Jimbo, J Wulfkuhle, et al.
Oncogene|September 22, 2015
ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expressionE Sánchez-Tilló, O de Barrios, E Valls, et al.
Oncogene|September 22, 2015
Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cellsF Nitzki, N Cuvelier, J Dräger, et al.
Oncogene|September 22, 2015
Targeting PYK2 mediates microenvironment-specific cell death in multiple myelomaM B Meads, B Fang, L Mathews, et al.
Oncogene|August 11, 2015
Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasionS-Y Yen, S-R Chen, J Hsieh, et al.
Oncogene|August 11, 2015
Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancerD Merino, S W Lok, J E Visvader, et al.
Pageof 2,202